How to completely cure pneumonia in children?

Written by Li Jiao Yan
Neonatology
Updated on September 14, 2024
00:00
00:00

Childhood pneumonia is mainly due to the weaker resistance of children, who are then subjected to the invasion of pathogens such as bacteria, viruses, or other agents like chlamydia and mycoplasma, leading to inflammation of the alveoli. Generally, the treatment of pneumonia is mainly targeted at its pathogens. For instance, antiviral treatment is administered for viral infections, antibacterial and anti-inflammatory treatments are required for bacterial infections, and specific antibiotics such as azithromycin or erythromycin are used for mycoplasma infections. For other types like tuberculosis and some other fungal pneumonias, specific treatments targeting those pathogens are also necessary. If the baby clearly has symptoms like wheezing or difficulty in breathing, symptomatic treatment is required. Therefore, pneumonia in children is mainly treated based on the cause, and as long as the course of treatment is sufficient, it can be cured completely. However, even after recovery, it does not mean a child will never contract pneumonia again. If the child has weak immunity or is in a high-risk environment with exposure to other patients with pneumonia cough, they might be infected again.

Other Voices

doctor image
home-news-image
Written by Han Shun Li
Pulmonology
37sec home-news-image

The difference between Mycoplasma pneumonia and Chlamydia pneumonia

Mycoplasma pneumonia and Chlamydia pneumonia are clinically similar, making them difficult to distinguish from each other as both have similar symptoms and treatment options. Treatments such as erythromycin and quinolones can be used for both. The main difference between them lies in the laboratory tests. If tests for pneumonia, Mycoplasma antibodies or antigens are positive, then it is diagnosed as Mycoplasma pneumonia. If tests for Chlamydia pneumonia antibodies are positive, or if a throat swab test detects Chlamydia, then it is diagnosed as Chlamydia pneumonia.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 18sec home-news-image

The function of the pneumonia vaccine

Pneumonia vaccines are generally aimed at preventing infections caused by Streptococcus pneumoniae. There are two common types of vaccines: the 23-valent polysaccharide vaccine, which is suitable for high-risk populations over two years old, and the 7-valent or 13-valent conjugate vaccines, which are mainly used for vaccinating infants under two years of age. Streptococcus pneumoniae is the most common and widespread bacterium causing pneumonia, and pneumonia caused by this bacterium is also the most prevalent worldwide. It is also the most significant pathogen in community-acquired pneumonia in children and a major cause of otitis media, meningitis, and bacteremia in children. The pneumonia vaccines mainly target common serotypes of Streptococcus pneumoniae, such as the 7-valent or 13-valent, designed to prevent infections from seven or thirteen serotypes, respectively, while the 23-valent vaccine aims to prevent infections from 23 serotypes. These pneumonia vaccines play a significant protective role in preventing infections caused by Streptococcus pneumoniae, however, they cannot prevent all cases of pneumonia.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
59sec home-news-image

How many shots are in the pneumonia vaccine?

Currently, there are two general types of vaccines for preventing pneumococcal pneumonia. One type is the 23-valent vaccine, suitable for high-risk populations over two years old. The other type includes the 7-valent or 13-valent vaccines, which are for preventing pneumococcal infections in infants under two years old. Infants under two usually follow a "three plus one" vaccination regimen, which involves three primary immunization doses with at least one month between each dose, followed by a booster shot. Additionally, adults over two years old or other high-risk groups are advised to take the 23-valent vaccine, which requires only a single dose. However, those who are frail or have poor immune responses may need a second booster dose five years after the initial vaccination.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 24sec home-news-image

How to completely cure pneumonia in children?

Childhood pneumonia is mainly due to the weaker resistance of children, who are then subjected to the invasion of pathogens such as bacteria, viruses, or other agents like chlamydia and mycoplasma, leading to inflammation of the alveoli. Generally, the treatment of pneumonia is mainly targeted at its pathogens. For instance, antiviral treatment is administered for viral infections, antibacterial and anti-inflammatory treatments are required for bacterial infections, and specific antibiotics such as azithromycin or erythromycin are used for mycoplasma infections. For other types like tuberculosis and some other fungal pneumonias, specific treatments targeting those pathogens are also necessary. If the baby clearly has symptoms like wheezing or difficulty in breathing, symptomatic treatment is required. Therefore, pneumonia in children is mainly treated based on the cause, and as long as the course of treatment is sufficient, it can be cured completely. However, even after recovery, it does not mean a child will never contract pneumonia again. If the child has weak immunity or is in a high-risk environment with exposure to other patients with pneumonia cough, they might be infected again.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
55sec home-news-image

How many doses are there for the pneumonia vaccine?

Currently, there are two types of vaccines commonly used to prevent pneumococcal diseases. One type is the 23-valent polysaccharide vaccine, suitable for high-risk populations over two years old. The other type includes the 7-valent or 13-valent conjugate vaccines, used for vaccinating infants under two years old. The vaccination schedule for the 7-valent or 13-valent vaccines follows a "three plus one" program, which means three primary immunization doses with at least one month between each dose, followed by a booster dose. For the 23-valent vaccine, high-risk individuals over two years old generally require only a single dose; however, immunocompromised patients may need a booster shot, typically recommended five years after the initial vaccination.